ReCor Medical
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, ReCor Medical sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
ReCor Medical: 5 sponsored US clinical trials, 2 recruiting.
ReCor Medical sponsors 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Vascular Diseases, with 5 trials.
Upper-quartile sponsor footprint
ReCor Medical sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
The RADIANCE CED Study
NCT07231757
Global Paradise System US Post Approval Study
NCT06297291
RADIANCE Continued Access Protocol
NCT05017935
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NCT03614260
A Study of the ReCor Medical Paradise System in Clinical Hypertension
NCT02649426
Therapeutic Areas
What is open in the ReCor Medical pipeline
2 recruiting of 5 indexed (40% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Vascular Diseases (5 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
ReCor Medical: open-pipeline peers nationwide
Peers matched on 5 registered trials and 40% open enrollment, not the therapeutic-area sidebar.
ReCor Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 40% open enrollment (± trial volume)
- Ad scientiam · 40% recruiting · 5 trials
- Alto Neuroscience · 40% recruiting · 10 trials
- Bonafide Health · 40% recruiting · 5 trials
- Brooks Rehabilitation · 40% recruiting · 5 trials
Related
What to do with this ReCor Medical page
5 registered trials is a research-attention snapshot, not an endorsement of ReCor Medical or any single study.
- 2 of ReCor Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Vascular Diseases is the condition ReCor Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vascular Diseases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. ReCor Medical pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.